Last Updated:
Gorilla Healing was an online seller in the gray-area peptide market, best known, at least in customer reviews, for its Wolverine Nasal spray. It operated under the “do your own research” zone, which was far enough outside the medical system to feel underground, but close enough to mainstream biohacking culture to seem legitimate.
Then the FDA came knocking.
The unravelling of Gorilla Healing didn’t happen overnight. It started with FDA warning letters, then shipping failures, dead inboxes, angry reviews, and eventually a transformation to Peptidist.
On October 2, 2023, the FDA issued a warning letter to www.gorillahealing.com stating that the website was selling “misbranded and unapproved new drugs” — specifically semaglutide and tirzepatide, which are diabetes and weight-loss peptides.
The FDA’s position was that the brand was marketing products that qualify as drugs (based on claims and intent) without FDA approval. The FDA also emphasized that these compounds are prescription drugs, and therefore can’t legally be sold to consumers without the proper labeling that would allow safe use.
On top of this, the letter raised concerns that the products were intended for injection but did not provide preparation or dosing instructions, increasing the risk of contamination and serious outcomes.
Gorilla Healing was active for at least 6-7 years, selling gray-area compounds such as TB-500, BPC-157, and its flagship Wolverine nasal spray, but it seems the FDA drew the line at semaglutide and tirzepatide.
Both semaglutide and tirzepatide already exist on the U.S. market as FDA-approved prescription drugs, sold under brand names like Ozempic, Rybelsus, Wegovy, and Mounjaro.
These drugs are tightly regulated, prescription-only, and have warning labels, including risk language related to thyroid C-cell tumors. In other words, these are compounds the FDA considers serious enough to require direct medical supervision.
The agency has also repeatedly warned that unapproved GLP-1 products sold online come with unique risks.
Without FDA review, these products may vary in purity or potency, lack meaningful safety data, and could be distributed without proper medical oversight. In some cases, the FDA has raised concerns that consumers may not even be receiving the same active ingredient used in approved drugs.
For Gorilla Healing, selling peptides in a regulatory gray zone was one thing, but selling potentially knockoff or unapproved versions of blockbuster prescription drugs was another entirely — and it seems like this was the breaking point for regulatory tolerance.
A week after the FDA letter was issued, Reuters reported that Gorilla Healing was still operating and still listing semaglutide and tirzepatide for sale. In the article, Gorilla Healing told Reuters that it had not seen the FDA warning addressed directly to it.
We can’t say for certain whether or not this was true, but it’s clear that the letter enforcement didn’t flip the off switch for the company. However, customers started to feel a collapse.
From late 2023 to 2024, customer complaints about Gorilla Healing began to stack up across Trustpilot and the Better Business Bureau.
Customers repeatedly reported paying for products that were never shipped, alongside support channels that appeared to stop working altogether.
“Company took payment and never sent product. Attempts to contact company indicate their email support address does not exist.”
— BBB complaint, May 2024
Others described weeks of silence after placing orders, even as their payments cleared.
“Placed an order with Gorilla Healing on 4/13/24. My check cleared the bank on 4/15/24. As of 4/24/24 no products have been shipped. No customer support. All emails fail.”
— Trustpilot review, April 2024
Meanwhile, long-time customers — some with years of prior orders — expressed disbelief at how abruptly things changed.
“I have done business with them several times with no problem. Now, not a word.”
— Trustpilot review, April 2024
The website did eventually shut down, but was replaced with peptidist.com.
There wasn’t a public announcement of the company shutdown or even an apology sent to customers. It seemed like Gorilla Healing never acknowledged that anything was wrong.
The company just let the operational breakdown happen — orders took longer to ship if they shipped at all, support emails stopped working, and payment issues became more common.
When you visit gorillahealing.com, you’re rerouted to a new website peptisit.com.
There’s no official confirmation from either company that Gorilla Healing and Peptidist are connected. No press release. No “we’ve rebranded” announcement.
But when you line up the details, the overlap is hard to ignore.
Peptidist’s domain was registered on July 29, 2024, months after the FDA warning letter and right around the period when Gorilla Healing’s site and customer support began breaking down.
Around the same time, Wolverine nasal spray — Gorilla Healing’s most recognizable product — reappeared under the Peptidist name, with the same marketing and formulation.
Early Peptidist reviews make the connection even clearer.
Multiple customers say they found Peptidist while searching for Gorilla Healing or Wolverine specifically, suggesting they weren’t discovering a new brand so much as following the trail of an old one.
Later reviews in mid to late 2025 start to sound familiar, describing payment issues, bounced emails, and growing doubts about whether anyone is actually behind the site anymore.
Some reviews put it bluntly: “Looks like the old Peptidist is gone and replaced by a scam site.”
For years, Gorilla Healing built trust on results and word of mouth. But once regulation, logistics, and oversight came into play, that trust began to crack.
Gorilla Healing didn’t fall apart because people stopped believing in peptides. It seems like it crashed because the business couldn’t, or wouldn’t, adapt fast enough when the rules changed.
What came after may look like a familiar fix, even one that sells the same products. But the trail of complaints, warnings, and unanswered questions tells a different story.
And that’s the real lesson here: in the gray market, trust is everything — and once it breaks, it’s nearly impossible to recover.
The takeaway is straightforward: if a peptide brand can’t show testing, communicate clearly, and stay reachable, don’t buy from them. When those basics disappear, problems usually show up after your money is already gone.
Written by
Founder & Wellness Advocate
